Georg Beyer1, Ujjwal M Mahajan1, Christoph Budde2, Thomas J Bulla2, Thomas Kohlmann3, Louise Kuhlmann4, Kerstin Schütte5, Ali A Aghdassi2, Eckhard Weber2, F Ulrich Weiss2, Asbjørn M Drewes4, Søren S Olesen4, Markus M Lerch2, Julia Mayerle6. 1. Department of Medicine A, Universitätsmedizin Greifswald, Ernst-Moritz-Arndt-University Greifswald, Germany; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany. 2. Department of Medicine A, Universitätsmedizin Greifswald, Ernst-Moritz-Arndt-University Greifswald, Germany. 3. Institut für Community Medicine, Universitätsmedizin Greifswald, Ernst-Moritz-Arndt-Universität Greifswald, Germany. 4. Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. 5. Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany. 6. Department of Medicine A, Universitätsmedizin Greifswald, Ernst-Moritz-Arndt-University Greifswald, Germany; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany. Electronic address: Julia.mayerle@med.uni-muenchen.de.
Abstract
BACKGROUND & AIMS: The clinical course of chronic pancreatitis is unpredictable. There is no model to assess disease severity or progression or predict patient outcomes. METHODS: We performed a prospective study of 91 patients with chronic pancreatitis; data were collected from patients seen at academic centers in Europe from January 2011 through April 2014. We analyzed correlations between clinical, laboratory, and imaging data with number of hospital readmissions and in-hospital days over the next 12 months; the parameters with the highest degree of correlation were used to develop a 3-stage chronic pancreatitis prognosis score (COPPS). The predictive strength was validated in 129 independent subjects identified from 2 prospective databases. RESULTS: The mean number of hospital admissions was 1.9 (95% confidence interval [CI], 1.39-2.44) and 15.2 for hospital days (95% CI, 10.76-19.71) for the development cohort and 10.9 for the validation cohort (95% CI, 7.54-14.30) (P = .08). Based on bivariate correlations, pain (numeric rating scale), level of glycated hemoglobin A1c, level of C-reactive protein, body mass index, and platelet count were used to develop the COPPS system. The patients' median COPPS was 8.9 points (range, 5-14). The system accurately discriminated stages of disease severity (low to high): A (5-6 points), B (7-9), and C (10-15). In Pearson correlation analysis of the development cohort, the COPPS correlated with hospital admissions (0.39; P < .01) and number of hospital days (0.33; P < .01). The correlation was validated in the validation set (Pearson correlation values of 0.36 and 0.44; P < .01). COPPS did not correlate with results from the Cambridge classification system. CONCLUSIONS: We developed and validated an easy to use dynamic multivariate scoring system, similar to the Child-Pugh-Score for liver cirrhosis. The COPPS allows objective monitoring of patients with chronic pancreatitis, determining risk for readmission to hospital and potential length of hospital stay.
BACKGROUND & AIMS: The clinical course of chronic pancreatitis is unpredictable. There is no model to assess disease severity or progression or predict patient outcomes. METHODS: We performed a prospective study of 91 patients with chronic pancreatitis; data were collected from patients seen at academic centers in Europe from January 2011 through April 2014. We analyzed correlations between clinical, laboratory, and imaging data with number of hospital readmissions and in-hospital days over the next 12 months; the parameters with the highest degree of correlation were used to develop a 3-stage chronic pancreatitis prognosis score (COPPS). The predictive strength was validated in 129 independent subjects identified from 2 prospective databases. RESULTS: The mean number of hospital admissions was 1.9 (95% confidence interval [CI], 1.39-2.44) and 15.2 for hospital days (95% CI, 10.76-19.71) for the development cohort and 10.9 for the validation cohort (95% CI, 7.54-14.30) (P = .08). Based on bivariate correlations, pain (numeric rating scale), level of glycated hemoglobin A1c, level of C-reactive protein, body mass index, and platelet count were used to develop the COPPS system. The patients' median COPPS was 8.9 points (range, 5-14). The system accurately discriminated stages of disease severity (low to high): A (5-6 points), B (7-9), and C (10-15). In Pearson correlation analysis of the development cohort, the COPPS correlated with hospital admissions (0.39; P < .01) and number of hospital days (0.33; P < .01). The correlation was validated in the validation set (Pearson correlation values of 0.36 and 0.44; P < .01). COPPS did not correlate with results from the Cambridge classification system. CONCLUSIONS: We developed and validated an easy to use dynamic multivariate scoring system, similar to the Child-Pugh-Score for liver cirrhosis. The COPPS allows objective monitoring of patients with chronic pancreatitis, determining risk for readmission to hospital and potential length of hospital stay.
Authors: Christopher E Forsmark; Dana K Andersen; John T Farrar; Megan Golden; Aida Habtezion; Sohail Z Husain; Liang Li; Julia Mayerle; Stephen J Pandol; Aliye Uc; Zixi Zhu; Dhiraj Yadav Journal: Pancreas Date: 2018 Nov/Dec Impact factor: 3.327
Authors: Mats L Wiese; Simone Gärtner; Nele von Essen; Julia Doller; Fabian Frost; Quang Trung Tran; Frank Ulrich Weiss; Fatuma Meyer; Luzia Valentini; Leif-A Garbe; Cornelia C Metges; Karen Bannert; Lea Franziska Sautter; Luise Ehlers; Robert Jaster; Georg Lamprecht; Antje Steveling; Markus M Lerch; Ali A Aghdassi Journal: Front Nutr Date: 2022-06-01
Authors: Julia B Greer; Phil Greer; Bimaljit S Sandhu; Samer Alkaade; C Mel Wilcox; Michelle A Anderson; Stuart Sherman; Timothy B Gardner; Michele D Lewis; Nalini M Guda; Thiruvengadam Muniraj; Darwin Conwell; Gregory A Cote; Christopher E Forsmark; Peter A Banks; Gong Tang; Kim Stello; Andres Gelrud; Randall E Brand; Adam Slivka; David C Whitcomb; Dhiraj Yadav Journal: Nutr Clin Pract Date: 2018-08-13 Impact factor: 3.080
Authors: Monica Cheng; Mark A Gromski; Evan L Fogel; John M DeWitt; Aashish A Patel; Temel Tirkes Journal: Br J Radiol Date: 2021-04-16 Impact factor: 3.039
Authors: Temel Tirkes; Zarine K Shah; Naoki Takahashi; Joseph R Grajo; Stephanie T Chang; Sudhakar K Venkatesh; Darwin L Conwell; Evan L Fogel; Walter Park; Mark Topazian; Dhiraj Yadav; Anil K Dasyam Journal: Radiology Date: 2018-10-16 Impact factor: 29.146
Authors: Serena Stigliano; Alexander Waldthaler; Emma Martinez-Moneo; Luana Lionetto; Stuart Robinson; Marko Malvik; Aleksandra Hedstrom; Aleksandra Kaczka; Marius Scholdei; Stephan Haas; Maurizio Simmaco; Gianfranco Delle Fave; Matthias Lohr; Peter Simon; Gabriele Capurso Journal: Clin Transl Gastroenterol Date: 2018-10-15 Impact factor: 4.488